|
市場調査レポート
商品コード
1446236
在宅輸液療法の世界市場 2024-2028Global Home Infusion Therapy Market 2024-2028 |
||||||
カスタマイズ可能
|
在宅輸液療法の世界市場 2024-2028 |
出版日: 2024年02月27日
発行: TechNavio
ページ情報: 英文 158 Pages
納期: 即納可能
![]() |
在宅輸液療法市場は2023-2028年に173億7,000万米ドル、予測期間中のCAGRは8.12%で成長すると予測されます。
当レポートでは、在宅輸液療法市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、輸液ポンプや遠隔監視装置の技術進歩、慢性疾患の有病率の増加、長期的な医療ケアを必要とする世界の老人人口の増加が牽引しています。
市場範囲 | |
---|---|
基準年 | 2024 |
終了年 | 2028 |
予測期間 | 2024-2028 |
成長モメンタム | 加速 |
前年比2024年 | 7.58% |
CAGR | 8.12% |
増分額 | 173億7,000万米ドル |
本調査では、今後数年間における在宅輸液療法市場の成長を促進する主な要因の1つとして、患者ケアと治療オプションの開発およびコラボレーションの増加を挙げています。また、在宅輸液療法が提供するサービスと統合された専門薬局サービスの需要拡大や、在宅輸液のための専門医療従事者の増加も、市場の大きな需要につながります。
Exhibits:
The home infusion therapy market is forecasted to grow by USD 17.37 bn during 2023-2028, accelerating at a CAGR of 8.12% during the forecast period. The report on the home infusion therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in infusion pumps and remote monitoring devices, increasing prevalence of chronic diseases, and growing geriatric population worldwide requiring long-term medical care.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 7.58% |
CAGR | 8.12% |
Incremental Value | $17.37bn |
Technavio's home infusion therapy market is segmented as below:
By Application
By Product
By Geographical Landscape
This study identifies the increasing developments and collaborations for patient care and therapeutic options as one of the prime reasons driving the home infusion therapy market growth during the next few years. Also, expanding demand for specialty pharmacy services integrated with home infusion therapy offerings and rising initiations on specialized healthcare professionals for home infusion will lead to sizable demand in the market.
The report on the home infusion therapy market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading home infusion therapy market vendors that include B.Braun SE, Baxter International Inc., Becton Dickinson and Co., Bio-Med Pvt. Ltd., Cardinal Health Inc., Catholic Health Initiatives, Community Surgical Supply, Fresenius SE and Co. KGaA, Health Vista Pvt Ltd., Health2home, ICU Medical Inc., Medix Infusion, Nipro Corp., Option Care Health Inc., Prochant, Reviv Genetics Ltd., Sober Care Surgical, UnitedHealth Group Inc., University of Pennsylvania Health System, and Walgreens Boots Alliance Inc.. Also, the home infusion therapy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.